Alkhurma hemorrhagic fever is a viral infection that can cause high fever, headache, muscle aches, and sometimes bleeding. People with Alkhurma hemorrhagic fever often feel very weak, and some develop nausea, vomiting, or liver and neurologic problems. Illness usually starts suddenly and can worsen over days, and severe cases may be life threatening. It has been reported mainly in parts of Saudi Arabia and neighboring regions, and risk is higher for people exposed to livestock, ticks, or animal blood. Treatment for Alkhurma hemorrhagic fever is supportive with fluids, careful monitoring, and hospital care when needed.
Overview
Alkhurma hemorrhagic feverSymptoms
Alkhurma hemorrhagic fever often starts suddenly with high fever, headache, muscle aches, and fatigue. Early symptoms of Alkhurma hemorrhagic fever can include nausea, vomiting, and diarrhea. Some develop bleeding (nose, gums, bruising), dizziness, or low blood pressure.
Outlook and prognosis
Many people with Alkhurma hemorrhagic fever recover with careful monitoring, fluids, and support in hospital. Severe illness can develop quickly, so early care improves survival and reduces complications like bleeding or organ strain. Recovery may take weeks with gradual strength returning.
Causes and risk factors
Alkhurma hemorrhagic fever stems from Alkhurma virus, usually via tick bites or contact with blood or raw milk from infected livestock; risk is higher for farmers, abattoir workers, livestock handlers, travelers to endemic areas, and those pregnant, older, or immunocompromised.
Genetic influences
Genetics plays little to no role in Alkhurma hemorrhagic fever; it’s an infection acquired from virus exposure, not inherited. Genetic variations in people don’t meaningfully change risk or outcomes. The virus and exposure route drive who gets sick.
Diagnosis
Alkhurma hemorrhagic fever is diagnosed from symptoms and exposure history plus lab tests. Confirmation uses PCR on blood or antibody tests, while doctors rule out dengue, Crimean‑Congo hemorrhagic fever, and similar illnesses; seek diagnosis of Alkhurma hemorrhagic fever after exposure.
Treatment and drugs
Treatment for Alkhurma hemorrhagic fever focuses on careful supportive care: fluids to prevent dehydration, medicines for fever and pain (avoiding aspirin/NSAIDs), and monitoring for bleeding or low blood pressure. Severe cases may need IV fluids, blood products, and critical care. Antibiotics don’t help this viral illness.
Symptoms
Alkhurma hemorrhagic fever causes a sudden illness that can start like the flu and, in some cases, progress quickly. Symptoms vary from person to person and can change over time. The early symptoms of Alkhurma hemorrhagic fever often include high fever, headache, and body aches, sometimes with nausea. In severe illness, bleeding, confusion, or fainting can develop and need urgent medical care.
High fever often comes on suddenly with chills and sweating. You may feel wiped out and need to rest. Fever can last several days.
Severe, throbbing headache is common, often behind the eyes or across the forehead. Bright light may feel uncomfortable. It can be hard to concentrate or read.
Achy muscles and sore joints can make movement feel effortful. Simple tasks like climbing stairs may take more energy. The aches can be widespread.
Nausea, vomiting, and loss of appetite are frequent early signs. In Alkhurma hemorrhagic fever, these stomach symptoms may come with abdominal cramps. Keeping fluids down can be difficult.
How people usually first notice Alkhurma hemorrhagic fever?
People often first notice Alkhurma hemorrhagic fever a few days after a tick bite or contact with animal blood—usually from livestock—when a sudden high fever, headache, muscle aches, and profound fatigue set in, sometimes with nausea or vomiting. As it progresses over hours to a couple of days, warning signs can include bleeding from the nose or gums, easy bruising, red eyes, or a rash, along with dizziness or confusion. Many seek care when the fever doesn’t break and bleeding or severe weakness appears, especially after recent travel or work in areas where the virus is known to circulate.
Types of Alkhurma hemorrhagic fever
Alkhurma hemorrhagic fever is an acute viral infection, so clinicians describe variations by how the illness shows up rather than by genetic subtypes of the virus. Symptoms don’t always look the same for everyone. Broadly, symptoms are grouped into phases that can overlap, from early nonspecific signs to more severe bleeding problems in a smaller subset. Understanding these types of Alkhurma hemorrhagic fever presentations can help people recognize early symptoms of Alkhurma hemorrhagic fever and seek care quickly.
Early febrile phase
Sudden fever, headache, muscle aches, and fatigue are common. Nausea, vomiting, and sometimes light sensitivity can occur. Many improve after several days with supportive care.
Gastrointestinal-predominant
Stomach pain, repeated vomiting, and diarrhea stand out more than other symptoms. People may feel dehydrated and weak, sometimes with mild bleeding from the gums. For many, certain types stand out more than others.
Hepatic involvement
The liver becomes inflamed, leading to jaundice with yellowing of the eyes and dark urine. Labs show elevated liver enzymes, and people can feel profound tiredness. Close monitoring is needed to watch for worsening.
Hemorrhagic form
Bruising, nosebleeds, bleeding gums, or blood in vomit can appear. This severe type may also bring low blood pressure and shock, requiring urgent hospital care. Not everyone will experience every type.
Neurologic involvement
Confusion, severe headache, or neck stiffness can develop in some cases. Seizures are rare but possible when the brain is affected. This form needs prompt evaluation to rule out other causes.
Convalescent phase
Fatigue and low appetite can linger after the fever settles. Some may have a slow return to normal energy and sleep over days to weeks. Keeping track of which type you experience most can help your care team tailor follow-up.
What genetics can tell you about symptoms
People with certain immune gene variants, like changes in HLA or interferon pathway genes, may have stronger inflammation and higher fever, bleeding, or liver strain. Variants affecting clotting or platelet function can raise bruising, nosebleeds, or prolonged bleeding risk.
Causes and risk factors
The illness is caused by a virus spread mainly by ticks, and infection often starts after a tick bite. You can also get Alkhurma hemorrhagic fever when handling or slaughtering infected animals, with exposure to their blood or tissues. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Risk factors for Alkhurma hemorrhagic fever include living or traveling in affected parts of the Arabian Peninsula, outdoor work or camping, close contact with camels, goats, or sheep, and not using tick protection. There are no known genetic risks, but older age and conditions that weaken the immune system may raise the chance of severe illness.
Environmental and biological risk factors
Risk factors for Alkhurma hemorrhagic fever center on what you’re exposed to in certain settings and how your body responds after that exposure. Some risks are carried inside the body, others come from the world around us. If you live, work, or travel near livestock in regions where this virus circulates, your chances of contact can rise. Below are the environmental and biological factors that can increase the likelihood of infection.
Bites from infected hard ticks can pass the virus during feeding. Crushing ticks with bare fingers can also push virus into small skin breaks.
Handling, slaughtering, or butchering livestock exposes skin and mucous membranes to infected blood or tissues. Splashing into eyes, nose, or mouth increases the chance of infection.
Drinking raw milk or handling raw animal products from infected animals has been linked to transmission. Unprocessed products can carry virus from the animal to people.
Work that involves close contact with livestock or ticks, such as herding, slaughterhouse work, or veterinary care, increases exposure opportunities. Repeated contact in these settings raises cumulative risk.
Genetic risk factors
There are no known inherited causes of Alkhurma hemorrhagic fever. Research has not identified specific genetic risk factors for Alkhurma hemorrhagic fever, and genetic testing is not part of routine care. Risk is not destiny—it varies widely between individuals. Differences in immune-response genes may shape how people handle viral infections in general, but AHF-specific links remain unproven.
Not inherited disease: Alkhurma hemorrhagic fever is caused by a virus and is not passed down through genes. Having the condition does not mean relatives are genetically at higher risk.
No proven gene markers: No specific gene variant has been validated to increase susceptibility or severity in AHF. At this time, genetic testing cannot estimate personal risk or predict outcomes.
Immune system disorders: Rare inherited immune deficiencies can make many viral infections more severe. In AHF, direct evidence for this effect is limited.
Antiviral defense genes: Genes that guide early antiviral defenses influence responses to several related viruses. For AHF, clear associations have not been shown.
Family history limits: A family history of Alkhurma hemorrhagic fever does not point to an inherited risk pattern. Reported cases have not shown the kind of inheritance seen with genetic diseases.
Ancestry and sex genes: No consistent links with ancestry or sex-linked genes have been verified for AHF. Available data are small, so firm conclusions cannot yet be drawn.
Lifestyle risk factors
For Alkhurma hemorrhagic fever, everyday behaviors around animals, food, and outdoor activities largely determine exposure risk. This overview focuses on lifestyle risk factors for Alkhurma hemorrhagic fever and practical steps that lower them. Diet choices and the way you work or play outdoors can meaningfully shift your risk of infection.
Drinking raw or unpasteurized camel, goat, or sheep milk can transmit virus if the animal is infected. Choosing pasteurized dairy eliminates this route.
Eating undercooked meat, organs, or fresh blood during traditional practices can expose you to infectious tissues. Thorough cooking to safe temperatures reduces this risk.
Home butchering or handling carcasses without gloves or eye protection increases contact with infected blood. Using gloves, face shields, and careful handling lowers exposure.
Skipping repellents, permethrin-treated clothing, and body checks raises the chance of tick bites in farms or brush. Consistent repellents and end-of-day tick checks reduce transmission risk.
Risk prevention
You can lower the chance of Alkhurma hemorrhagic fever by avoiding tick bites and contact with animal blood or raw milk in places where the virus is found. Prevention is about lowering risk, not eliminating it completely. There’s no vaccine, so everyday steps matter most when working with livestock, visiting farms or markets, or traveling to affected regions. Knowing the early symptoms of Alkhurma hemorrhagic fever can help you seek care quickly after a tick bite or animal exposure.
Wear long sleeves and pants, and tuck pants into socks in brush or animal areas. Use repellents with DEET or picaridin on skin and permethrin on clothing.
Check your body after outdoor work and remove ticks promptly with fine‑tipped tweezers. Grasp close to the skin, pull straight out, and wash the area; do not crush ticks with bare fingers.
Avoid bare‑skin contact with animal blood or tissues, especially from camels, goats, or sheep. Use gloves, eye protection, and cover any cuts when handling animals or carcasses.
Skip raw milk and fresh, unpasteurized dairy products. Choose pasteurized dairy, or boil milk to a rolling boil if pasteurization is uncertain.
Transmission
Alkhurma hemorrhagic fever is usually passed to people through bites from infected ticks, often those that live on camels, sheep, or goats. People can also get Alkhurma hemorrhagic fever when infected animal blood or tissues get into a cut or splash into the eyes or mouth during tasks like slaughtering or handling raw meat; even crushing ticks with bare fingers can be a risk.
There’s no evidence it spreads through everyday contact between people—not by breathing the same air, casual touch, or shared surfaces—and healthcare spread would require direct contact with infected blood without proper protection. Overall, Alkhurma hemorrhagic fever is not highly contagious between people, but avoiding tick bites and using safe animal‑handling practices are the main ways to lower risk.
When to test your genes
Alkhurma hemorrhagic fever is an acute viral infection, not an inherited disorder, so routine genetic testing isn’t useful. Test your genes only if a clinician suspects an underlying immune or clotting disorder that could change prevention or treatment. Otherwise, focus on exposure prevention and seek prompt medical care after risk or symptoms.
Diagnosis
Alkhurma hemorrhagic fever is usually suspected when a sudden high fever and bleeding symptoms appear after recent tick exposure or contact with animals in an area where the virus circulates. For many, the first step comes when everyday activities start feeling harder, such as needing to lie down after small tasks because of fever, headache, and body aches. From here, the focus shifts to confirming or ruling out possible causes. The diagnosis of Alkhurma hemorrhagic fever relies on a mix of exposure history, exam findings, basic labs, and virus-specific tests done in the right time window.
Clinicians ask about recent travel to endemic regions, tick bites, or contact with camels, sheep, or during animal slaughter. Timing matters—symptoms typically start a few days to two weeks after exposure.
Providers look for sudden fever, severe headache, muscle aches, nausea, and any bleeding from gums or nose or easy bruising. Dizziness, fatigue, or low appetite can add helpful clues.
A complete blood count and chemistry panel often show low platelets, low white cells, and elevated liver enzymes. These patterns support suspicion for a viral hemorrhagic fever and guide urgency of care.
Prothrombin time, aPTT, and fibrinogen help assess bleeding risk. Abnormal results may point toward a hemorrhagic process and help plan monitoring and supportive care.
Stages of Alkhurma hemorrhagic fever
Alkhurma hemorrhagic fever does not have defined progression stages. The illness usually starts suddenly and can range from a short, flu‑like episode to more serious problems such as bleeding or liver and nervous system involvement, so it doesn’t follow a predictable, step‑by‑step pattern. Doctors consider early symptoms of Alkhurma hemorrhagic fever—like fever, headache, muscle aches, nausea—alongside recent tick exposure, animal contact, or travel to areas where the virus is found, plus an exam and routine blood work. Different tests may be suggested to help confirm the cause (for example PCR or antibody testing) and to monitor blood counts, liver enzymes, and clotting.
Outlook and prognosis
Looking at the long-term picture can be helpful. For most people with Alkhurma hemorrhagic fever, the course is short but intense, with symptoms peaking over days to a couple of weeks. Early symptoms of Alkhurma hemorrhagic fever often include fever, severe headache, and body aches; a smaller group develops bleeding, confusion, or organ strain. The risk of severe disease and death varies by outbreak and access to care; reported case‑fatality rates have ranged roughly from 1% up to about 30% in limited settings, but with rapid supportive treatment, survival is much higher. Everyone’s journey looks a little different.
Doctors call this the prognosis—a medical word for likely outcomes. Most people who recover do so fully, though fatigue or low appetite can linger for several weeks. There is no evidence of long-term contagiousness after recovery, and relapse appears uncommon. Serious complications, when they occur, usually happen early, driven by dehydration, bleeding, or liver and kidney stress; this is why timely fluids, monitoring, and treatment of complications matter. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
People living with Alkhurma hemorrhagic fever who receive prompt care generally regain their usual routines within weeks, while those with delayed treatment or underlying conditions face higher risks in the acute phase. Mortality is concentrated among people who develop shock, severe bleeding, or multi‑organ failure; intensive care can be lifesaving in these situations. With ongoing care, many people maintain good health after recovery and do not have chronic organ problems. Talk with your doctor about what your personal outlook might look like.
Long-term effects
For most people, Alkhurma hemorrhagic fever is an acute illness with recovery over weeks rather than months. Severe cases can take longer to rebound, especially if the liver or kidneys were affected during the illness. There is no clear evidence of ongoing, chronic infection after recovery. Long-term effects vary widely, so follow-up focuses on how you’re feeling and how key organs are healing.
Many people regain their usual strength within several weeks to a few months. Lab tests often move back toward normal as the body heals. Lasting disability after recovery appears uncommon.
Tiredness and low stamina can persist for weeks after the fever ends. For some, early symptoms of Alkhurma hemorrhagic fever are followed by a slow return to previous energy levels. Most people improve gradually with time.
The illness can inflame the liver, leading to temporarily abnormal enzymes. These values usually settle over weeks as inflammation eases. Ongoing liver damage is not typical in survivors.
In severe illness, the kidneys may be stressed or injured. Kidney function often improves as overall health returns. Some people need short-term monitoring until values normalize.
How is it to live with Alkhurma hemorrhagic fever?
Days can feel unpredictable with Alkhurma hemorrhagic fever: sudden high fever, severe headache, muscle pain, and profound fatigue can make even simple tasks hard, and dehydration can sneak up quickly if you’re not drinking enough. Some people develop nausea, bleeding from gums or nose, or easy bruising, which can be frightening and usually requires medical care and rest away from others to prevent complications. Family and coworkers may need to help with daily needs, monitor for warning signs like worsening weakness or bleeding, and practice careful hygiene and tick or animal exposure precautions to lower risk. Recovery can take days to weeks, so pacing activities, staying hydrated, and following medical advice helps most people regain strength while those around them stay informed and supportive.
Treatment and drugs
Treatment for Alkhurma hemorrhagic fever focuses on supportive care because there’s no specific antiviral proven to work against this virus. In hospital, people with Alkhurma hemorrhagic fever often receive IV fluids to prevent dehydration, careful monitoring of blood pressure and oxygen levels, and treatment for pain and fever; medicines that increase bleeding risk, like aspirin or ibuprofen, are usually avoided. If bleeding occurs, doctors may give platelet or plasma transfusions and manage any organ strain, such as kidney or liver support, as needed. Antibiotics don’t help the virus itself, but may be used if there’s a concern for a secondary bacterial infection. Supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Care focuses on supportive measures to keep fluids up, protect organs, and lower bleeding risk. Non-drug treatments often lay the foundation for recovery when care starts early and is closely monitored. For many, recognizing early symptoms of Alkhurma hemorrhagic fever and seeking care quickly allows these supports to start before complications develop. People are typically managed in the hospital for observation and prevention measures to protect others.
Oral rehydration solutions and frequent small sips help replace fluids and salts. If vomiting or dehydration is severe, IV fluids can stabilize blood pressure and protect the kidneys. This is central supportive care for Alkhurma hemorrhagic fever.
Tepid sponging, cool compresses, light clothing, and a fan can help ease fever and discomfort. Staying hydrated and avoiding overheating also support recovery.
Bed rest reduces strain on the body during the acute phase. As symptoms ease, short, gentle activities with frequent breaks can help rebuild strength.
Use a soft toothbrush, avoid nose blowing or picking, and treat skin gently to lower bleeding risk. Limit injections and blood draws to those that are essential, and apply firm pressure after any needle stick. These steps matter in Alkhurma hemorrhagic fever, which can raise bleeding risk.
Your genes may have an impact on how drugs work for you
Genetic differences can change how your body absorbs, breaks down, and clears antiviral or supportive medications for Alkhurma hemorrhagic fever, affecting dose needs and side‑effects. In some settings, clinicians may use pharmacogenetic guidance to choose safer, more effective dosing.
Pharmacological treatments
There’s no specific antiviral medicine proven to cure Alkhurma hemorrhagic fever, so care focuses on medications that support the body while it heals. Alongside drug therapy, careful monitoring and infection control remain important. Treatment aims to control fever and nausea, keep fluids and blood pressure steady, and manage bleeding or clotting problems. In severe illness, intensive care with blood products and medicines to support circulation may be needed.
Early symptoms of Alkhurma hemorrhagic fever like fever and body aches can be eased with acetaminophen (paracetamol). It lowers discomfort without raising bleeding risk, unlike aspirin or ibuprofen.
Isotonic fluids such as normal saline or lactated Ringer’s help maintain hydration and blood pressure. Doctors adjust the rate based on vitals, urine output, and lab results.
Ondansetron can reduce nausea and vomiting to help prevent dehydration and allow oral fluids. This often makes it easier to keep food and medicines down.
Platelets and fresh frozen plasma may be used to treat bleeding and clotting problems. They are given based on platelet counts and clotting tests.
Genetic influences
For Alkhurma hemorrhagic fever, the main driver is exposure to infected ticks or animal products, not genes passed down in a family. Genetics is only one piece of the puzzle, but small differences in immune response or blood-clotting genes may influence how severe the illness becomes for some people. So far, no single gene has been shown to cause or prevent Alkhurma hemorrhagic fever, and family clusters usually reflect shared exposures rather than inherited risk. The virus itself can also differ; genetic changes in certain strains may affect how strongly it impacts the body. Because the evidence is limited, there isn’t a test to estimate your genetic risk for Alkhurma hemorrhagic fever, and routine genetic testing isn’t used to predict who will get it or how severe it will be. Prevention focuses on lowering exposure risk, and clinicians manage suspected infections based on clinical signs, not on a person’s genetic profile.
Is Alkhurma hemorrhagic fever genetic?
Genetics plays little to no role in Alkhurma hemorrhagic fever; it’s an infection acquired from virus exposure, not inherited. Genetic variations in people don’t meaningfully change risk or outcomes. The virus and exposure route drive who gets sick.
Pharmacogenetics—how genetics influence drug effects
Care for Alkhurma hemorrhagic fever is mostly supportive, so treatment often involves fluids and medicines for fever, pain, and nausea while doctors watch for bleeding. Genes can influence how quickly you process some of these drugs, which can change how well they work or whether side effects show up. Common differences in liver enzyme genes can make medicines like codeine, tramadol, or ondansetron work too weakly or too strongly, so your team may choose alternatives if they suspect this pattern. If an antiviral such as ribavirin is considered on a case‑by‑case basis, certain inherited differences have been linked to the risk of ribavirin‑related anemia, so close blood monitoring is essential regardless of genetics. Because acute infection can strain the liver and kidneys and increase bleeding risk, clinicians often avoid nonsteroidal anti‑inflammatory drugs and adjust doses based on organ function first, using pharmacogenetic testing for Alkhurma hemorrhagic fever treatment only when an unexpected drug response occurs or results would clearly change a choice. Genes are just part of the picture—illness severity, age, and other medicines also guide which options are safest and most effective.
Interactions with other conditions
Living with Alkhurma hemorrhagic fever can be harder if another health issue is in the mix, especially conditions that already affect bleeding or organ function. Another important aspect is how it may link with other diseases. Preexisting liver problems (such as chronic hepatitis or cirrhosis) can impair clotting and make bleeding more severe, and kidney disease can add to fluid and electrolyte strain during a serious infection. In regions where exposures overlap, co-infections with other tick- or mosquito-borne illnesses—like dengue, malaria, or rickettsial diseases—can mimic early symptoms of Alkhurma hemorrhagic fever and delay diagnosis; shared features such as low platelets and dehydration can compound the risk of complications. Medicines taken for other conditions that thin the blood (for example, warfarin, certain antiplatelet drugs, or even some over‑the‑counter pain relievers like ibuprofen) may raise bleeding risk during Alkhurma hemorrhagic fever, and immune‑suppressing treatments can make infections harder to control. Pregnancy and chronic conditions such as diabetes or heart disease may also increase the chance of severe outcomes, so coordinated care across specialties is especially important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden fevers that swept through households after animal slaughter or travel through dry grasslands. In parts of the Arabian Peninsula, community stories often described the condition as a severe illness that struck butchers, farmers, and people handling livestock, especially during peak tick seasons. Families noticed it tended to appear after a bite or after contact with raw animal products, then fade from view until the next cluster.
First described in the medical literature as a severe hemorrhagic fever linked to livestock exposure near Jeddah in the 1990s, Alkhurma hemorrhagic fever came into clearer focus as clinicians connected early symptoms of Alkhurma hemorrhagic fever—sudden high fever, headache, and fatigue—to a virus carried by ticks. Early reports were small and sometimes confusing, mixing it with other fevers common in the region. Over time, careful lab testing and tracing of exposures made its pattern more distinct.
From these first observations, scientists learned that Alkhurma hemorrhagic fever was not limited to one city. Cases appeared in other areas of Saudi Arabia and, rarely, in travelers returning to different countries after visiting rural zones or working with animals. With each decade, diagnostic tools improved. Blood tests that could spot the virus more reliably helped separate it from dengue, Rift Valley fever, and other lookalike illnesses common in the same climates.
Initially understood only through symptoms, later work clarified how people most often became infected—through bites from infected ticks, or contact with blood or tissues of animals carrying the virus. This matched long-standing practices in many communities where home slaughter, outdoor herding, and tick exposure are part of daily life. Public health teams began sharing practical steps: reduce tick bites, use protective clothing, handle raw animal products carefully, and seek care early for sudden high fever after exposure.
As medical science evolved, researchers mapped the virus’s relatives and placed it among other tick-borne hemorrhagic fevers, explaining why its course could range from mild to severe. Not every early description was complete, yet together they built the foundation of today’s knowledge. Awareness spreads mainly through local health services and travel clinics, which helps clinicians consider Alkhurma hemorrhagic fever in the right context—recent travel, animal contact, or tick bites—so people get prompt testing and care.